Cisplatin

Formulations: - Parenteral > General injections > unspecified: 10 mg in vial powder for injection; 50 mg in vial powder for injection Parenteral > General injections > IV: 10 mg per 10 mL; 20 mg per 20 mL; 50 mg per 50 mL; 100 mg per 100 mL Parenteral > General injections > IV: 50 mg per 50 mL; 100 mg per 100 mL; 10 mg per 10 mL; 20 mg per 20 mL Indications: - Unspecified malignant neoplasms of ill-defined or unspecified sites - Other specified gliomas of brain - Other specified malignant neoplasms of the ovary - Other specified malignant neoplasms of bronchus or lung - Malignant neoplasms of nasopharynx - Germ cell tumour of testis - Malignant neoplasms of other or ill-defined sites in the lip, oral cavity or pharynx - Osteosarcoma of bone and articular cartilage of unspecified sites - Malignant neoplasms of cervix uteri - Malignant neoplasms of hypopharynx - Malignant neoplasms of oropharynx Source: EML workbook import